[1] HOSSAIN MS,KARUNIAWATI H,JAIROUN AA,et al.Colorectal cancer:A review of carcinogenesis,global epidemiology,current challenges,risk factors,preventive and treatment strategies [J].Cancers,2022,14(7):1732.
[2] HIBINO S,KAWAZOE T,KASAHARA H,et al.Inflammation-induced tumorigenesis and metastasis [J].Int J Mol Sci,2021,22(11):5421.
[3] MOHRI Y,MIKI C,KOBAYASHI M,et al.Correlation between preoperative systemic inflammation and postoperative infection in patients with gastrointestinal cancer:a multicenter study [J].Surgery Today,2013,44(5):859-867.
[4] HUSZNO J,KOLOSZA Z,MROCHEM-KWARCIAK J,et al.The role of neutrophil-lymphocyte ratio,platelet-lymphocyte ratio,and platelets in the prognosis of metastatic renal cell carcinoma [J].Oncology,2019,97(1):7-17.
[5] HUANG H,LIU Q,ZHU L,et al.Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer [J].Sci Rep,2019,9(1):3284.
[6] LIU J,LI S,ZHANG S,et al.Systemic immune-inflammation index,neutrophil-to-lymphocyte ratio,platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab [J].J Clin Lab Anal,2019,33(8):e22964.
[7] 张宇,汪亦民,薛英威.全身免疫炎症指数(SII)与胃癌患者临床病理因素及预后的相关性[J].现代肿瘤医学,2021,29(3):441-445.
ZHANG Y,WANG YM,XUE YW.Relationship between systemic immune-inflammatory index(SII) and clinical pathological features and prognosis in patients with gastric cancer[J].Modern Oncology,2021,29(3):441-445.
[8] YEH CC,KAO HK,HUANG Y,et al.Discovering the clinical and prognostic role of pan-immune-inflammation values on oral cavity squamous cell carcinoma [J].Cancers (Basel),2023,15(1):322.
[9] GUVEN DC,SAHIN TK,ERUL E,et al.The association between the pan-immune-inflammation value and cancer prognosis:a systematic review and Meta-analysis [J].Cancers (Basel),2022,14(11):2675.
[10] FUC G,GUARINI V,ANTONIOTTI C,et al.The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer:results from a pooled-analysis of the Valentino and TRIBE first-line trials [J].Br J Cancer,2020,123(3):403-409.
[11] TECCHIO C,CASSATELLA MA.Neutrophil-derived chemokines on the road to immunity [J].Semin Immunol,2016,28(2):119-128.
[12] TAN KW,CHONG SZ,WONG FH,et al.Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D [J].Blood,2013,122(22):3666-3677.
[13] SHIBUTANI M,MAEDA K,NAGAHARA H,et al.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer [J].World J Gastroenterol,2015,21(34):9966-9973.
[14] LEE SWL,ADRIANI G,KAMM RD,et al.Models for monocytic cells in the tumor microenvironment [J].Adv Exp Med Biol,2020,1224:87-115.
[15] FENG F,ZHENG G,WANG Q,et al.Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer [J].BMC Gastroenterol,2018,18(1):148.
[16] 陈莉玲,张礼,李玥伶,等.术前血小板计数与结直肠癌患者预后的关系[J].南方医科大学学报,2016,36(4):482-487.
CHEN LL,ZHANG L,LI YL,et al.Association of preoperative platelet count with the prognosis of patients with colorectal cancer [J].J South Med Univ,2016,36(4):482-487.
[17] CHEN X,HONG X,CHEN G,et al.The pan-immune-inflammation value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor [J].Transl Oncol,2022,17:101338.
[18] FUC G,BENINATO T,BINI M,et al.The pan-immune-inflammation value in patients with metastatic melanoma receiving first-line therapy [J].Target Oncol,2021,16(4):529-536.
[19] LIN F,ZHANG LP,XIE SY,et al.Pan-immune-inflammation value:A new prognostic index in operative breast cancer [J].Front Oncol,2022,12:830138.
[20] FENG L,XU R,LIN L,et al.Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer:a retrospective cohort study [J].J Gastrointest Oncol,2022,13(5):2333-2339.
[21] TAN DJH,YAOW CYL,MOK HT,et al.The influence of diabetes on postoperative complications following colorectal surgery [J].Tech Coloproctol,2021,25(3):267-278.
[22] BREM H,TOMIC-CANIC M.Cellular and molecular basis of wound healing in diabetes [J].J Clin Invest,2007,117(5):1219-1222.
[23] GEERLINGS SE,HOEPELMAN AI.Immune dysfunction in patients with diabetes mellitus (DM) [J].FEMS Immunol Med Microbiol,1999,26(3-4):259-265.
[24] 朱渝军,陈刚,胡佳,等.腹腔镜与开腹手术治疗结直肠癌的临床疗效及术后并发症的比较[J].实用癌症杂志,2016,31(01):103-106.
ZHU YJ,CHEN G,HU J,et al.Comparison of clinical efficacy and complications of laparoscopic operation and laparotomy in the treatment of colorectal cancer [J].The Practical Journal of Cancer,2016,31(01):103-106.